Severe EBV hepatitis treated with valganciclovir

R. Pisapia, A. Mariano, A. Rianda, A. Testa, A. Oliva, L. Vincenzi

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

We describe the case of an 18-year-old immunocompetent male patient with severe hepatitis during primary Epstein-Barr virus infection, treated with oral valganciclovir. During the initial therapy with corticosteroids, the patient's clinical condition and liver function worsened, so we decided to add oral valganciclovir for its good bio-availability and previous encouraging experiences in different clinical settings, with rapid resolution of the symptoms.

Original languageEnglish
Pages (from-to)251-254
Number of pages4
JournalInfection
Volume41
Issue number1
DOIs
Publication statusPublished - Feb 2013

Fingerprint

Human Herpesvirus 4
Hepatitis
Epstein-Barr Virus Infections
Adrenal Cortex Hormones
Liver
valganciclovir
Therapeutics

Keywords

  • Epstein-Barr virus infection
  • Hepatitis
  • Therapy
  • Valganciclovir

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Severe EBV hepatitis treated with valganciclovir. / Pisapia, R.; Mariano, A.; Rianda, A.; Testa, A.; Oliva, A.; Vincenzi, L.

In: Infection, Vol. 41, No. 1, 02.2013, p. 251-254.

Research output: Contribution to journalArticle

@article{5fe9b04a1db64e25849447a17087c25b,
title = "Severe EBV hepatitis treated with valganciclovir",
abstract = "We describe the case of an 18-year-old immunocompetent male patient with severe hepatitis during primary Epstein-Barr virus infection, treated with oral valganciclovir. During the initial therapy with corticosteroids, the patient's clinical condition and liver function worsened, so we decided to add oral valganciclovir for its good bio-availability and previous encouraging experiences in different clinical settings, with rapid resolution of the symptoms.",
keywords = "Epstein-Barr virus infection, Hepatitis, Therapy, Valganciclovir",
author = "R. Pisapia and A. Mariano and A. Rianda and A. Testa and A. Oliva and L. Vincenzi",
year = "2013",
month = "2",
doi = "10.1007/s15010-012-0303-0",
language = "English",
volume = "41",
pages = "251--254",
journal = "Infection",
issn = "0300-8126",
publisher = "Urban und Vogel GmbH",
number = "1",

}

TY - JOUR

T1 - Severe EBV hepatitis treated with valganciclovir

AU - Pisapia, R.

AU - Mariano, A.

AU - Rianda, A.

AU - Testa, A.

AU - Oliva, A.

AU - Vincenzi, L.

PY - 2013/2

Y1 - 2013/2

N2 - We describe the case of an 18-year-old immunocompetent male patient with severe hepatitis during primary Epstein-Barr virus infection, treated with oral valganciclovir. During the initial therapy with corticosteroids, the patient's clinical condition and liver function worsened, so we decided to add oral valganciclovir for its good bio-availability and previous encouraging experiences in different clinical settings, with rapid resolution of the symptoms.

AB - We describe the case of an 18-year-old immunocompetent male patient with severe hepatitis during primary Epstein-Barr virus infection, treated with oral valganciclovir. During the initial therapy with corticosteroids, the patient's clinical condition and liver function worsened, so we decided to add oral valganciclovir for its good bio-availability and previous encouraging experiences in different clinical settings, with rapid resolution of the symptoms.

KW - Epstein-Barr virus infection

KW - Hepatitis

KW - Therapy

KW - Valganciclovir

UR - http://www.scopus.com/inward/record.url?scp=84873708603&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873708603&partnerID=8YFLogxK

U2 - 10.1007/s15010-012-0303-0

DO - 10.1007/s15010-012-0303-0

M3 - Article

C2 - 22837057

AN - SCOPUS:84873708603

VL - 41

SP - 251

EP - 254

JO - Infection

JF - Infection

SN - 0300-8126

IS - 1

ER -